Avita Medical (RCEL) announced it has entered into an exclusive distribution agreement with Revolution Surgical. This agreement marks an important milestone in our expansion into the Australian and New Zealand markets. Under the terms of the agreement, Revolution Surgical will serve as the exclusive distributor of the Recell product platform, including Recell GO, in Australia and New Zealand. This partnership aims to enhance the availability and accessibility of Avita Medical’s products to a broader customer base in these regions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCEL: